United States
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

                                   (Mark One)

[x]  Quarterly Report Pursuant To Section 13 Or 15(d) Of The Securities Exchange
     Act Of 1934 For the Period Ended December 31, 2000

                                       or

[ ] Transition Report Pursuant To Section 10 Or 15(d) Of The Securities Exchange
    Act Of 1934 For The Transition Period From ____________  To  ___________

Commission File Number 0-15449

                      CALIFORNIA MICRO DEVICES CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                     California                              94-2672609
                     ----------                              ----------
         (State or other jurisdiction of                  (I.R.S. Employer
         incorporation or organization)                   Identification No.)

    215 Topaz Street, Milpitas, California                   95035-5430
    --------------------------------------                   ----------
   (Address of principal executive offices)                  (Zip Code)

                                 (408) 263-3214
                                 --------------
              (Registrant's telephone number, including area code)

                                 Not applicable
                                 --------------
                        (Former name, former address, and
                former fiscal year if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.     Yes   X            No
                                          --------          -------

                      Applicable Only to Corporate Issuers

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

As of December 31, 2000,  there were outstanding  11,309,074  shares of Issuer's
Common Stock.





                      CALIFORNIA MICRO DEVICES CORPORATION

                                      INDEX

                          PART I. FINANCIAL INFORMATION

                                                                     Page Number
                                                                     -----------

Item 1.     Financial Statements

              Statements of Operations
                   Three and Nine Months Ended December 31, 2000 and 1999      2

              Balance Sheets
                   December 31, 2000 and March 31, 2000                        3

              Statements of Cash Flows
                   Nine Months Ended December 31, 2000 and 1999                4

              Notes to Financial Statements                                    5

Item 2.     Management's Discussion and Analysis of Financial Condition
               and Results of Operations                                       8

Item 3.     Quantitative and Qualitative Disclosures About Market Risk        10

                           PART II. OTHER INFORMATION

Item 1.     Legal Proceedings                                                 11

Item 6.     Exhibits and Reports on Form 8-K                                  11

Signature                                                                     11





ITEM 1. Financial Statements.


                      CALIFORNIA MICRO DEVICES CORPORATION
                            STATEMENTS OF OPERATIONS
                  (Amounts in Thousands, Except Per Share Data)
                                   (Unaudited)


                                               Three Months Ended     Nine Months Ended
                                                   December 31,          December 31,
                                               -------------------   -------------------
                                                 2000       1999       2000       1999
                                               --------   --------   --------   --------
                                                                    
Net sales                                      $ 14,507   $ 11,664   $ 45,495   $ 29,619

Cost and expenses:
  Cost of sales                                   9,076      7,867     29,401     20,716
  Research and development                          892        762      2,603      2,489
  Selling, marketing and administrative           3,031      2,463      8,695      6,611
                                               --------   --------   --------   --------
    Total costs and expenses                     12,999     11,092     40,699     29,816
                                               --------   --------   --------   --------

Operating income (loss)                           1,508        572      4,796       (197)
Other expense, net                                  170         92        711        397
                                               --------   --------   --------   --------
Income (loss) before income taxes                 1,338        480      4,085       (594)

Income taxes                                         28       --           83       --
                                               --------   --------   --------   --------

Net income (loss)                              $  1,310   $    480   $  4,002   $   (594)
                                               ========   ========   ========   ========

Net income (loss) per share - basic            $   0.12   $   0.05   $   0.36   $  (0.06)
                                               ========   ========   ========   ========

Weighted average common shares
  outstanding -basic                             11,286     10,284     11,196     10,205
                                               ========   ========   ========   ========

Net income (loss) per fully diluted share      $   0.11   $   0.04   $   0.32   $  (0.06)
                                               ========   ========   ========   ========

Weighted average fully diluted common shares
outstanding                                      12,245     11,528     12,437     10,205
                                               ========   ========   ========   ========

<FN>
The accompanying notes are an integral part of these financial statements.
</FN>

                                       2





                      CALIFORNIA MICRO DEVICES CORPORATION
                                 BALANCE SHEETS
                    (Amounts in Thousands, Except Share Data)


                                                            December 31,  March 31,
                                                                2000       2000*
                                                              --------    --------
                                                            (Unaudited)
                                                                    
ASSETS:
Current assets:
  Cash and short-term securities                              $  2,681    $  1,490
  Short-term investments                                         5,190       5,069
  Accounts receivable, net of allowance for doubtful
    accounts of $273 and $219                                    8,806       8,875
  Inventories                                                   12,222       9,994
  Prepaid expenses and other assets                              1,419         980
                                                              --------    --------
    Total current assets                                        30,318      26,408

Property, plant & equipment, net                                13,359      10,637
Restricted cash                                                  1,212         902
Other long term assets                                           1,081       1,139
                                                              --------    --------

    Total assets                                              $ 45,970    $ 39,086
                                                              ========    ========

LIABILITIES & SHAREHOLDERS' EQUITY:
Current liabilities:
  Accounts payable                                            $  4,579    $  4,821
  Accrued salaries and benefits                                  1,389       1,097
  Other accrued liabilities                                        680         742
  Deferred margin on shipments to distributors                     600         516
  Current maturities of long-term debt and capital
    lease obligations                                            1,131         815

                                                              --------    --------
    Total current liabilities                                    8,379       7,991

Long-term debt, less current maturities                          8,885       7,342
Other long-term liabilities and capital leases less current
  maturities                                                       601         793
                                                              --------    --------
    Total liabilities                                           17,865      16,126

Shareholders' equity:
  Common stock - no par value; authorized 25,000,000;
    issued and outstanding: 11,309,074 as of December
    31, 2000 and 11,037,543 as of March 31, 2000                57,628      56,479
  Accumulated deficit                                          (29,525)    (33,528)
  Accumulated other comprehensive income                             2           9
                                                              --------    --------
    Total shareholders' equity                                  28,105      22,960
                                                              --------    --------

  Total liabilities and shareholders' equity                  $ 45,970    $ 39,086
                                                              ========    ========

<FN>
* Derived from audited financial statements.

The accompanying notes are an integral part of these financial statements.
</FN>


                                       3





                      CALIFORNIA MICRO DEVICES CORPORATION
                            STATEMENTS OF CASH FLOWS
                             (Amounts in Thousands)
                                   (Unaudited)


                                                                            Nine Months Ended
                                                                               December 31,
                                                                           ------------------
                                                                             2000       1999
                                                                           -------    -------
                                                                                
Cash flows from operating activities:
  Net income (loss)                                                        $ 4,002    $  (594)
  Adjustments to reconcile net (loss)
     to net cash provided by operating activities:
  Depreciation and amortization                                              2,209      2,159
  Net increase in inventories                                               (2,228)    (1,014)
  Net (increase)/decrease in accounts receivable                                69     (2,103)
  Net increase in prepaid expenses and other current assets                   (439)      (621)
  Net increase/(decrease) in trade accounts payable
     and other current liabilities                                             (12)     1,590
  Net (increase)/decrease in other long term assets                             46        (97)
  Net increase/(decrease) in other long term liabilities                       (24)       111
  Increase / (decrease) in deferred margin on distributor sales                 84        (60)
                                                                           -------    -------
Net cash provided by (used in) operating activities                          3,707       (629)
                                                                           -------    -------

Cash flows from investing activities:
  Short-term investment purchases                                           (7,841)    (1,960)
  Short-term investment sales                                                7,714      2,707
  Capital expenditures                                                      (4,919)      (857)
  Net change in restricted cash                                               (310)     1,708
                                                                           -------    -------
Net cash provided by (used in) investing activities                         (5,356)     1,598
                                                                           -------    -------

Cash flows from financing activities:
  Repayments of capital lease obligations                                     (306)      (280)
  Additions to capital leases                                                 --          238
  Repayments of long-term debt                                                (263)      (125)
  Borrowings of long term debt                                               2,260       --
  Proceeds from issuance of common stock                                     1,149        931
                                                                           -------    -------
Net cash provided by financing activities                                    2,840        764
                                                                           -------    -------

Net increase in cash and cash equivalents                                    1,191      1,733
Cash and cash equivalents at beginning of period                             1,490        762
                                                                           -------    -------
Cash and cash equivalents at end of period                                 $ 2,681    $ 2,495
                                                                           =======    =======

Supplemental disclosures of cash flow information:
Interest paid                                                              $   723    $   670
Income taxes paid                                                             --         --

Supplemental disclosures of non-cash investing and financing activities:
    Unrealized gain/(loss) on securities                                   $    (7)   $   (15)
    Additions to capital financed by leases                                $  --      $   238

<FN>
The accompanying notes are an integral part of these financial statements.
</FN>

                                       4




                      CALIFORNIA MICRO DEVICES CORPORATION

                          Notes to Financial Statements

1.       Basis of Presentation

In the opinion of management,  the accompanying  unaudited  condensed  financial
statements   contain  all  adjustments  (which  include  only  normal  recurring
accruals)  necessary to present fairly  California  Micro Devices  Corporation's
(the  "Company")  financial  position  as  of  December  31,  2000,  results  of
operations  for the three and nine month  periods  ended  December  31, 2000 and
1999,  and cash flows for the  nine-month  periods  ended  December 31, 2000 and
1999.  Results  for the quarter are not  necessarily  indicative  of fiscal year
results.

The  condensed  financial  statements  should  be read in  conjunction  with the
financial  statements included with the Company's annual report on Form 10-K for
the fiscal year ended March 31, 2000.

2.       Use of Estimates

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent  liabilities at the date of the financial statements and the reported
amounts of revenues and expenses  during the reporting  period.  Actual  results
could differ from those estimates.

3.       Inventories

         The  components  of  inventory  consist of the  following  (amounts  in
thousands):

                                            December 31,          March 31,
                                                2000                 2000
                                            -------------        ------------
                      Raw materials           $     578           $     452
                      Work-in-process             7,409               6,473
                      Finished goods              4,235               3,069
                                            -------------        ------------
                                              $ 12,222            $  9,994
                                            =============        ============

4.       Litigation

The Company is a party to lawsuits,  claims,  investigations,  and  proceedings,
including  commercial  and  employment  matters,  which  are being  handled  and
defended in the ordinary course of business.  In the opinion of management,  the
ultimate disposition of these matters will not have a material adverse effect on
the  financial  condition or overall  trends in the results of operations of the
Company.

                                       5




5.       Net Income (Loss) Per Share


The  following  table sets forth the  computation  of basic and  diluted  income
(loss) per share:


                                                        Three months ended     Nine months ended
                                                            December 31,          December 31,
                                                        -------------------   -------------------
                                                          2000       1999       2000       1999
                                                        --------   --------   --------   --------
                                                         (In thousands, except per share amounts)
                                                                             
Numerator:
   Numerator for basic and diluted net income per
     share - net income (loss)                          $  1,310   $    480   $  4,002   $   (594)
                                                        ========   ========   ========   ========

Denominator for basic net income (loss) per share:
    Weighted average common hares used in computing
       basic net income per share                         11,286     10,284     11,196     10,205
                                                        ========   ========   ========   ========

Basic net income (loss) per share                       $   0.12   $   0.05   $   0.36   $  (0.06)
                                                        ========   ========   ========   ========

Denominator for diluted net income per share:
   Weighted average common shares                         11,286     10,284     11,196     10,205
   Employee stock options to purchase common stock           959      1,244      1,241       --
                                                        --------   --------   --------   --------
Shares used in computing diluted net income per share     12,245     11,528     12,437     10,205
                                                        ========   ========   ========   ========

  Diluted net income per share                          $   0.11   $   0.04   $   0.32   $  (0.06)
                                                        ========   ========   ========   ========


For the quarter  ended  December  31, 1999 and the quarter and nine months ended
December  31, 2000,  options to purchase  shares of common  stock,  representing
80,500 shares, 513,828 shares and 548,693 shares, respectively, were outstanding
during the period but were not included in the computation of diluted net income
per share  because the  options'  exercise  price was  greater  than the average
market  price  of  the  common  stock  and,  therefore,   the  effect  would  be
antidilutive.  For nine months ended  December 31,  1999,  2,517,000  options to
purchase  shares of common stock were excluded from the  computation  of diluted
net loss per share because the effect would be antidilutive.

6.      Comprehensive Income

Comprehensive  income  is  principally   comprised  of  net  income  (loss)  and
unrealized  gains or  losses  on the  Company's  available-for-sale  securities.
Comprehensive  income for the three months ended  December 31, 2000 and December
31, 1999 was  $1,307,000 and $469,000,  respectively.  For the nine months ended
December 31, 2000  comprehensive  income was  $3,996,000 and for the nine months
ended December 31, 1999, the comprehensive loss was $609,000.

7.       Income Taxes

For the three and nine months ended  December 31, 2000,  the Company  recorded a
provision  for income taxes of $28,000 and $83,000,  respectively,  based on the
projected  effective  annual tax rate of 2%. The  effective  tax rate for fiscal
2001  is  substantially  below  the  federal  statutory  rate  of 35% due to the
utilization of federal and state tax loss and credit  carryforwards.  No similar
amounts were recorded for the three and nine ended  December 31, 1999 due to the
Company's  year-to-date net loss during the period.  The Company's tax provision
consisted of federal and state alternative minimum taxes.

                                       6




8.       Recent Accounting Pronouncements

The Securities and Exchange  Commission (SEC) Staff Accounting  Bulletin No. 101
(SAB 101), "Revenue Recognition in Financial  Statements"  summarizes certain of
the SEC's views in applying generally accepted accounting  principles to revenue
recognition in financial  statements.  The Company will be required to adopt the
provisions of SAB 101 in the fourth  quarter of our fiscal year ending March 31,
2001. The net effect of adopting the statement will be accounted for as a change
in accounting  principle and will be reflected in the financial statements as if
the Company had adopted the  provisions  of the statement as of the beginning of
the financial  year. We are  reviewing our  compliance  with SAB 101, but do not
expect it to affect the  underlying  strength  and  weakness of our  business as
measured by the dollar value of the Company's shipments and cash flows.

9.       Capital Equipment Financing

The company has three equipment financing  facilities that have been utilized to
purchase manufacturing  equipment. In the quarter and nine months ended December
31, 2000 we borrowed $1.2 million and $2.2 million respectfully.  We have a $1.0
million  capital  equipment  financing  facility  that expires on July 31, 2003;
under the  terms of this  facility  we can  borrow at prime  plus  0.75%.  As of
December 31, 2000 we had borrowed  $1.0 million  against this capital  equipment
financing facility.  On April 21, 2000 we secured an additional $500,000 capital
equipment financing facility under the same terms and conditions as the original
facility.  The new line expires on August 31, 2003.  As of December 31, 2000, we
had borrowed  $500,000  against this  $500,000  facility.  On July 27, 2000,  we
secured an additional $2.0 million equipment  financing facility that expires on
December 25, 2003.  Under the terms of this facility we can borrow at prime plus
0.5%. As of December 31, 2000,  we had borrowed  $1.0 million  against this $2.0
million  capital  equipment  financing  facility.  We are in compliance with our
financial covenants.

                                       7




ITEM 2.  Management's Discussion And Analysis of Financial Condition and
         Results of Operations.

Results of Operations

Product sales for the quarter ended December 31, 2000,  increased by $2,843,000,
or 24%,  compared to the quarter ended  December 31, 1999,  with the majority of
the  increase  being in  products  for the  networking  market.  Unit  shipments
increased 43% to 33.3 million units in the December 31, 2000 quarter compared to
23.3  million  units in the  year-earlier  quarter.  The  increase  in sales was
primarily  due to increased  sales of new  products.  Sales of the Company's new
products  (products  introduced within the past three years) increased by 47% in
dollars and 65% in units in the quarter  ended  December 31, 2000 as compared to
the year-earlier  quarter. The most notable increase in new products was the PWR
family,  which  increased  174% in units  and 203% in  dollars  compared  to the
year-earlier quarter. Sales of the parallel port family were relatively flat.

Product  sales for the nine month period ended  December 31, 2000,  increased by
$15,876,000,  or 54%, over the year-earlier  period, also due to increased sales
of new  products,  with the majority of the  increase  being in products for the
networking  market.  Units shipped  increased 76% in the nine-month period ended
December 31, 2000 compared to the year-earlier period. New product sales for the
nine months  ended  December  31, 2000  increased  by 80% in dollars and 115% in
units as  compared  to the  year-earlier  period.  The PWR  family  of  products
increased  360% in  units  and  440% in  dollars  compared  to the  year-earlier
nine-month  period.  The number of parallel port solutions  shipped increased by
80% in the nine months ended  December 31, 2000 as compared to the  year-earlier
period,  but increased 32% in dollars due to the higher mix of lower cost single
chip solutions.

Gross  margins  increased to 37.4% in the December 31, 2000 quarter  compared to
32.6% in the  December  31,  1999  quarter and  increased  to 35.4% for the nine
months  ended  December  31, 2000  compared  to 30.0% for the nine months  ended
December 31, 1999 due to increased sales and manufacturing efficiencies.

Due to the widely  reported  weakness in the  computer,  telecommunications  and
networking  industries in which we participate and its impact on the electronics
and related components industries, we expect sales in the March 31, 2001 quarter
to be 10 to 15% lower than sales in the  December  31,  2000  quarter and expect
lower gross margins as a result.

Research and development  expense was $892,000 and $762,000 for the three months
ended  December 31, 2000 and 1999,  respectively,  and $2,603,000 and $2,489,000
for the nine months ended December 31, 2000 and 1999, respectively. The increase
in research and development expense was due to increased personnel costs.

Selling,  marketing and administrative expenses ("S, M & A") were $3,031,000 and
$2,463,000 for the three months ended December 31, 2000 and 1999,  respectively,
and $8,695,000 and $6,611,000 for the nine-month periods ended December 31, 2000
and 1999,  respectively.  The increases in the fiscal 2001 periods are primarily
due  to  increased   commissions,   increased  personnel  costs,  and  increased
promotional activities, including expansion of the Company's presence in Europe.

As a result of the  factors  discussed  above,  operating  income  for the three
months  ended  December  31, 2000,  was  $1,508,000  compared to $572,000 in the
year-earlier  period.  For the nine months ended December 31, 2000, there was an
operating  income of $4,796,000 as compared to an operating  loss of $197,000 in
the year earlier period.

Other  expense,  net for the three and nine months ended  December 31, 2000, was
$170,000 and $711,000 as compared to expense of $92,000 and $397,000 in the year
earlier periods. The increase in the nine months ended December 31, 2000 was due
primarily  to the  write-off  of  $250,000  of  expenses  related to a secondary
offering of the  Company's  stock that was withdrawn in September  2000,  due to
market conditions.

                                       8



Income taxes accrued for the three and nine months ended December 30, 2000, were
$28,000 and $83,000.  There were no income taxes  accrued for the three and nine
months  ended  December  31,  1999,  due to the  availability  of tax loss carry
forwards and the nine-month period losses.

Liquidity and Capital Resources

Total cash,  short-term  securities and investments as of December 31, 2000, was
$7.9 million compared to $6.6 million on March 31, 2000.  Receivables days sales
outstanding were 55 days as of December 31, 2000 as compared to 56 days at March
31, 2000. Inventories increased by $2.2 million from the March quarter,  related
primarily to increased  work-in-process to support new product introductions and
also due to the slowdown in the electronics  industry during the December,  2000
quarter.  Other current assets increased $439,000, to $1,419,000 at December 31,
2000,  due  to  prepaid  business  and  medical  insurance   premiums.   Capital
expenditures totaled $4.9 million, reflecting our investment in new equipment to
increase production and to support our production of chip scale products,  which
are  expected  to ramp up later this  calendar  year.  These  expenditures  were
partially offset by additional long term debt financing of $2.3 million.

We have a $3.0 million  revolving  secured line of credit agreement that expires
on June 30, 2001. Under the terms of the line of credit,  we can borrow at prime
plus one-half percent,  collateralized by eligible receivables.  We have made no
borrowings  against  this line.  We also have a $1.0 million  capital  equipment
financing  facility  that  expires  on July 31,  2003;  under  the terms of this
facility  we can borrow at prime plus  0.75%.  As of  December  31,  2000 we had
borrowed $1.0 million  against this capital  equipment  financing  facility.  On
April 21, 2000 we secured an additional  $500,000  capital  equipment  financing
facility under the same terms and conditions as the original  facility.  The new
line  expires on August 31,  2003.  As of December  31,  2000,  we had  borrowed
$500,000  against  this  $500,000  facility.  On July 27,  2000,  we  secured an
additional $2.0 million  equipment  financing  facility that expires on December
25, 2003.  Under the terms of this facility we can borrow at prime plus 0.5%. As
of December 31, 2000,  we had  borrowed  $1.0 million  against this $2.0 million
capital equipment  financing  facility.  We are in compliance with our financial
covenants.

We expect to fund our future  liquidity  needs through  existing cash  balances,
cash  flows from  operations,  bank  borrowings,  and  equipment  lease and loan
financing  arrangements.  Depending  on market  conditions  and the  results  of
operations, we may pursue other sources of liquidity.

We believe that we have  sufficient  financial  resources to fund its operations
for the foreseeable future.

Market Risk

We own financial  instruments  that are sensitive to market risks as part of our
investment  portfolio.  The  investment  portfolio  is used to preserve our cash
until it is required to fund operations and capital  investments.  None of these
market-risk  sensitive  instruments  are held for  trading  purposes  except for
amounts related to our non-qualified  deferred  compensation  program. We do not
own derivative financial instruments in our investment portfolio. The investment
portfolio  contains  instruments  that are  subject to  fluctuation  in interest
rates.

Our investment  portfolio  includes debt  instruments  that are primarily United
States  government bonds,  high-grade  corporate bonds and money market funds of
less than one year in duration.  These  investments are subject to interest rate
risk,  and could decline in value if interest  rates  increase.  Our  investment
portfolio  also  consists of certain  commercial  paper that is also  subject to
interest rate risk. Due to the short duration and  conservative  nature of these
instruments, we do not believe that we have a material exposure to interest rate
risk.

The interest rates on most of our long-term  debt and capital lease  obligations
are fixed and therefore not subject to interest rate fluctuations.

                                       9




Cautionary Statement

   This report contains forward-looking statements within the meaning of Section
   27A of the  Securities  Act of  1933,  as  amended,  and  Section  21E of the
   Securities  Act of 1934, as amended.  Except for the  historical  information
   contained in this  discussion of the business and the discussion and analysis
   of  financial  condition  and results of  operations,  the matters  discussed
   herein are forward-looking  statements.  Such forward-looking  statements are
   made  pursuant  to the  safe  harbor  provisions  of the  Private  Securities
   Litigation  Reform  Act of 1995.  The  forward-looking  statements  regarding
   revenues,  orders,  and sales  involve  a number of risks and  uncertainties,
   including  but not  limited to,  demand for the  Company's  product,  pricing
   pressures  which could  affect the  Company's  gross margin or the ability to
   consummate sales, unit volumes,  intense competition within the industry, the
   Company's ability to attract and retain high quality people, the need for the
   Company to keep pace with  technological  developments and respond quickly to
   changes in customer needs, the Company's  dependence on third party suppliers
   for  components  for  its  products,  cost  reductions,,  and  the  Company's
   dependence upon  intellectual  property rights which, if not available to the
   Company,  could have a material  adverse  effect on the  Company.  These same
   factors could also affect the liquidity needs of the Company.  Actual results
   could  differ   materially  from  those  projected  in  the   forward-looking
   statements  as a result of factors set forth above and elsewhere in this Form
   10-Q.  We  undertake  no  obligation  to  update  any of the  forward-looking
   statements in this report.

ITEM 3.  Quantitative and Qualitative Disclosures About Market Risk.

See discussion under the caption "Market Risk" in Item 2 above.

                                       10




                           PART II. OTHER INFORMATION

ITEM 1.  Legal Proceedings.

The Company is a party to lawsuits,  claims,  investigations,  and  proceedings,
including  commercial  and  employment  matters,  which  are being  handled  and
defended in the ordinary course of business.  In the opinion of management,  the
ultimate disposition of these matters will not have a material adverse effect on
the  financial  condition or overall  trends in the results of operations of the
Company.

ITEM 6.  Exhibits and Reports on Form 8-K.

         (a)      Exhibits

                  None

         (b)      Reports on Form 8-K

                  None

                                    SIGNATURE

Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                      CALIFORNIA MICRO DEVICES CORPORATION
                                  (Registrant)

Date:   February 12, 2001        /s/John E. Trewin
                                 ------------------------------------------
                                 John E. Trewin
                                 Vice President and Chief Financial Officer

                                       11